Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study

  • Geraldine Dominiak-Felden,
  • Corrado Gobbo,
  • François Simondon

The image for Fig 1 is incorrect. Please see the correct Fig 1 here.

thumbnail
Download:
Fig 1. Incidence of genital warts per 100 000 individuals (dashed line: females; solid line: males) and qHPV vaccine uptake in individuals aged 16–22 years (A), 23–30 years (B), 31–40 years (C) and 41–59 years (D) affiliated to the MLOZ sick fund (Belgium) between 2006 and 2013 (standardised estimates).

https://doi.org/10.1371/journal.pone.0148665.g001

There are errors in the fourth row of Table 2. Please see the corrected Table 2 here.

thumbnail
Download:
Table 2. Characteristics of the vaccine effectiveness study population as a function of their vaccination status.

https://doi.org/10.1371/journal.pone.0148665.t001

There is an error in the third sentence of the last paragraph of the Results section. The correct sentence is: In this second sensitivity analysis, the GWs IR was 113.9 (95%CI: 101.3–128.1) per 100,000 person-years in the non-qHPV vaccine group vs 14.2 (95% CI: 8.8; 22.8) per 100,000 person-years among women fully vaccinated with qHPV vaccine.

Reference

  1. 1. Dominiak-Felden G, Gobbo C, Simondon F (2015) Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. PLoS ONE 10(7): e0132404. pmid:26147096

Citation: Dominiak-Felden G, Gobbo C, Simondon F (2016) Correction: Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. PLoS ONE 11(1): e0148665. https://doi.org/10.1371/journal.pone.0148665

Published: January 29, 2016

Copyright: © 2016 Dominiak-Felden et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.